ENTRY       hsa04919                    Pathway
NAME        Thyroid hormone signaling pathway - Homo sapiens (human)
DESCRIPTION The thyroid hormones (THs) are important regulators of growth, development and metabolism. The action of TH is mainly mediated by T3 (3,5,3'-triiodo-L-thyronine). Thyroid hormones, L-thyroxine (T4) and T3 enter the cell through transporter proteins. Although the major form of TH in the blood is T4, it is converted to the more active hormone T3 within cells. T3 binds to nuclear thyroid hormone receptors (TRs), which functions as a ligand-dependent transcription factor and controls the expression of target genes (genomic action). Nongenomic mechanisms of action is initiated at the integrin receptor. The plasma membrane alpha(v)beta(3)-integrin has distinct binding sites for T3 and T4. One binding site binds only T3 and activates the phosphatidylinositol 3-kinase (PI3K) pathway. The other binding site binds both T3 and T4 and activates the ERK1/2 MAP kinase pathway.
CLASS       Organismal Systems; Endocrine system
PATHWAY_MAP hsa04919  Thyroid hormone signaling pathway
NETWORK     nt06322  TRH-TSH-TH signaling
  ELEMENT   N00798  Thyroid hormone signaling pathway
DRUG        D00562  Propylthiouracil (JP18/USP/INN)
            D01010  Levothyroxine sodium (USP)
            D01011  Liothyronine sodium (JP18/USP)
            D01012  Dried thyroid (JP18)
            D03750  Dextrothyroxine sodium (USAN)
            D06482  Thyroid (USP)
            D07214  Tiratricol (INN)
            D08125  Levothyroxine (BAN)
            D10604  Binimetinib (JAN/USAN/INN)
            D11113  Levothyroxine sodium (INN)
            D11602  Resmetirom (USAN/INN)
DBLINKS     GO: 0002154
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            10025  MED16; mediator complex subunit 16 [KO:K15159]
            10231  RCAN2; regulator of calcineurin 2 [KO:K17903]
            10499  NCOA2; nuclear receptor coactivator 2 [KO:K11255]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            113026  PLCD3; phospholipase C delta 3 [KO:K05857] [EC:3.1.4.11]
            116931  MED12L; mediator complex subunit 12L [KO:K15162]
            117247  SLC16A10; solute carrier family 16 member 10 [KO:K08187]
            1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]
            1499  CTNNB1; catenin beta 1 [KO:K02105]
            1733  DIO1; iodothyronine deiodinase 1 [KO:K01562] [EC:1.21.99.4]
            1734  DIO2; iodothyronine deiodinase 2 [KO:K17904] [EC:1.21.99.4]
            1735  DIO3; iodothyronine deiodinase 3 [KO:K07754] [EC:1.21.99.3]
            1827  RCAN1; regulator of calcineurin 1 [KO:K17901]
            2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            2099  ESR1; estrogen receptor 1 [KO:K08550]
            2308  FOXO1; forkhead box O1 [KO:K07201]
            23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
            23389  MED13L; mediator complex subunit 13L [KO:K15164]
            23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]
            2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]
            25942  SIN3A; SIN3 transcription regulator family member A [KO:K11644]
            2626  GATA4; GATA binding protein 4 [KO:K09183]
            2648  KAT2A; lysine acetyltransferase 2A [KO:K06062] [EC:2.3.1.48]
            29079  MED4; mediator complex subunit 4 [KO:K15146]
            2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
            3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
            3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
            3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]
            3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
            3685  ITGAV; integrin subunit alpha V [KO:K06487]
            3690  ITGB3; integrin subunit beta 3 [KO:K06493]
            3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]
            4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]
            4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]
            4624  MYH6; myosin heavy chain 6 [KO:K17751]
            4625  MYH7; myosin heavy chain 7 [KO:K17751]
            476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]
            477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]
            478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]
            480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]
            481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]
            482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]
            483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]
            4851  NOTCH1; notch receptor 1 [KO:K02599]
            4853  NOTCH2; notch receptor 2 [KO:K20994]
            4854  NOTCH3; notch receptor 3 [KO:K20995]
            4855  NOTCH4; notch receptor 4 [KO:K20996]
            486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]
            487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]
            488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]
            489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]
            4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]
            51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]
            5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
            5208  PFKFB2; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 [KO:K19029] [EC:2.7.1.105 3.1.3.46]
            5211  PFKL; phosphofructokinase, liver type [KO:K00850] [EC:2.7.1.11]
            5213  PFKM; phosphofructokinase, muscle [KO:K00850] [EC:2.7.1.11]
            5214  PFKP; phosphofructokinase, platelet [KO:K00850] [EC:2.7.1.11]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
            5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
            5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
            5333  PLCD1; phospholipase C delta 1 [KO:K05857] [EC:3.1.4.11]
            5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
            5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
            5350  PLN; phospholamban [KO:K05852]
            53919  SLCO1C1; solute carrier organic anion transporter family member 1C1 [KO:K08747]
            54361  WNT4; Wnt family member 4 [KO:K00408]
            5469  MED1; mediator complex subunit 1 [KO:K15144]
            5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
            5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
            5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
            5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            572  BAD; BCL2 associated agonist of cell death [KO:K02158]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            595  CCND1; cyclin D1 [KO:K04503]
            60  ACTB; actin beta [KO:K05692]
            6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]
            6256  RXRA; retinoid X receptor alpha [KO:K08524]
            6257  RXRB; retinoid X receptor beta [KO:K08525]
            6258  RXRG; retinoid X receptor gamma [KO:K08526]
            6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]
            652  BMP4; bone morphogenetic protein 4 [KO:K04662]
            6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]
            6567  SLC16A2; solute carrier family 16 member 2 [KO:K08231]
            6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]
            6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]
            7067  THRA; thyroid hormone receptor alpha [KO:K05547]
            7068  THRB; thyroid hormone receptor beta [KO:K08362]
            71  ACTG1; actin gamma 1 [KO:K05692]
            7157  TP53; tumor protein p53 [KO:K04451]
            7249  TSC2; TSC complex subunit 2 [KO:K07207]
            8202  NCOA3; nuclear receptor coactivator 3 [KO:K11256] [EC:2.3.1.48]
            842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]
            84812  PLCD4; phospholipase C delta 4 [KO:K05857] [EC:3.1.4.11]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            8648  NCOA1; nuclear receptor coactivator 1 [KO:K09101] [EC:2.3.1.48]
            8841  HDAC3; histone deacetylase 3 [KO:K11404] [EC:3.5.1.98]
            8850  KAT2B; lysine acetyltransferase 2B [KO:K06062] [EC:2.3.1.48]
            89869  PLCZ1; phospholipase C zeta 1 [KO:K05861] [EC:3.1.4.11]
            90390  MED30; mediator complex subunit 30 [KO:K15143]
            9282  MED14; mediator complex subunit 14 [KO:K15156]
            9440  MED17; mediator complex subunit 17 [KO:K15133]
            9442  MED27; mediator complex subunit 27 [KO:K15170]
            9611  NCOR1; nuclear receptor corepressor 1 [KO:K04650]
            9862  MED24; mediator complex subunit 24 [KO:K15167]
            9882  TBC1D4; TBC1 domain family member 4 [KO:K17902]
            9968  MED12; mediator complex subunit 12 [KO:K15162]
            9969  MED13; mediator complex subunit 13 [KO:K15164]
COMPOUND    C00076  Calcium cation
            C00080  H+
            C00165  Diacylglycerol
            C00238  Potassium cation
            C00575  3',5'-Cyclic AMP
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C01330  Sodium cation
            C01829  Thyroxine
            C02465  Triiodothyronine
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
            C07639  3,3',5'-Triiodo-L-thyronine
REFERENCE   PMID:20051527
  AUTHORS   Cheng SY, Leonard JL, Davis PJ
  TITLE     Molecular aspects of thyroid hormone actions.
  JOURNAL   Endocr Rev 31:139-70 (2010)
            DOI:10.1210/er.2009-0007
REFERENCE   PMID:16214361
  AUTHORS   Davis PJ, Davis FB, Cody V
  TITLE     Membrane receptors mediating thyroid hormone action.
  JOURNAL   Trends Endocrinol Metab 16:429-35 (2005)
            DOI:10.1016/j.tem.2005.09.007
REFERENCE   PMID:18329679
  AUTHORS   Davis PJ, Davis FB, Lin HY
  TITLE     Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors.
  JOURNAL   Steroids 73:1013-7 (2008)
            DOI:10.1016/j.steroids.2007.12.030
REFERENCE   PMID:22484490
  AUTHORS   Pascual A, Aranda A
  TITLE     Thyroid hormone receptors, cell growth and differentiation.
  JOURNAL   Biochim Biophys Acta 1830:3908-16 (2013)
            DOI:10.1016/j.bbagen.2012.03.012
REFERENCE   PMID:17983645
  AUTHORS   Davis PJ, Leonard JL, Davis FB
  TITLE     Mechanisms of nongenomic actions of thyroid hormone.
  JOURNAL   Front Neuroendocrinol 29:211-8 (2008)
            DOI:10.1016/j.yfrne.2007.09.003
REFERENCE   PMID:19755667
  AUTHORS   Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK
  TITLE     Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor.
  JOURNAL   Am J Physiol Endocrinol Metab 297:E1238-46 (2009)
            DOI:10.1152/ajpendo.00480.2009
REFERENCE   PMID:20868274
  AUTHORS   Davis PJ, Davis FB, Mousa SA, Luidens MK, Lin HY
  TITLE     Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
  JOURNAL   Annu Rev Pharmacol Toxicol 51:99-115 (2011)
            DOI:10.1146/annurev-pharmtox-010510-100512
REFERENCE   PMID:23021374
  AUTHORS   Lin HY, Tang HY, Davis FB, Mousa SA, Incerpi S, Luidens MK, Meng R, Davis PJ
  TITLE     Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps.
  JOURNAL   Discov Med 14:199-206 (2012)
REFERENCE   PMID:21835053
  AUTHORS   Moeller LC, Broecker-Preuss M
  TITLE     Transcriptional regulation by nonclassical action of thyroid hormone.
  JOURNAL   Thyroid Res 4 Suppl 1:S6 (2011)
            DOI:10.1186/1756-6614-4-S1-S6
REFERENCE   PMID:19295177
  AUTHORS   Bhargava M, Lei J, Ingbar DH
  TITLE     Nongenomic actions of L-thyroxine and 3,5,3'-triiodo-L-thyronine. Focus on "L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase".
  JOURNAL   Am J Physiol Cell Physiol 296:C977-9 (2009)
            DOI:10.1152/ajpcell.00116.2009
REFERENCE   PMID:17574003
  AUTHORS   Oetting A, Yen PM
  TITLE     New insights into thyroid hormone action.
  JOURNAL   Best Pract Res Clin Endocrinol Metab 21:193-208 (2007)
            DOI:10.1016/j.beem.2007.04.004
REFERENCE   PMID:20005976
  AUTHORS   Ojamaa K
  TITLE     Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.
  JOURNAL   Vascul Pharmacol 52:113-9 (2010)
            DOI:10.1016/j.vph.2009.11.008
REFERENCE   PMID:19716314
  AUTHORS   Aranda A, Martinez-Iglesias O, Ruiz-Llorente L, Garcia-Carpizo V, Zambrano A
  TITLE     Thyroid receptor: roles in cancer.
  JOURNAL   Trends Endocrinol Metab 20:318-24 (2009)
            DOI:10.1016/j.tem.2009.03.011
REFERENCE   PMID:16951130
  AUTHORS   Otulakowski G, O'Brodovich H
  TITLE     Thyroid hormone and Na+-K+-ATPase: more than simple transcription.
  JOURNAL   Am J Physiol Lung Cell Mol Physiol 292:L4-5 (2007)
            DOI:10.1152/ajplung.00332.2006
REFERENCE   PMID:16051672
  AUTHORS   Moeller LC, Dumitrescu AM, Refetoff S
  TITLE     Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes.
  JOURNAL   Mol Endocrinol 19:2955-63 (2005)
            DOI:10.1210/me.2004-0542
REFERENCE   PMID:15345678
  AUTHORS   D'Arezzo S, Incerpi S, Davis FB, Acconcia F, Marino M, Farias RN, Davis PJ
  TITLE     Rapid nongenomic effects of 3,5,3'-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways.
  JOURNAL   Endocrinology 145:5694-703 (2004)
            DOI:10.1210/en.2004-0890
REL_PATHWAY hsa00010  Glycolysis / Gluconeogenesis
            hsa04010  MAPK signaling pathway
            hsa04020  Calcium signaling pathway
            hsa04066  HIF-1 signaling pathway
            hsa04115  p53 signaling pathway
            hsa04150  mTOR signaling pathway
            hsa04151  PI3K-Akt signaling pathway
            hsa04260  Cardiac muscle contraction
            hsa04310  Wnt signaling pathway
            hsa04330  Notch signaling pathway
            hsa04810  Regulation of actin cytoskeleton
            hsa04918  Thyroid hormone synthesis
KO_PATHWAY  ko04919
///
